Document is current
Any future updates will be listed below
-
Authors
Odell, Anahi V.
Newton, Nathan M.
Eisenstein, Anna
Micevic, Goran https://orcid.org/0000-0003-0329-1053
Flavell, Richard A. https://orcid.org/0000-0003-4461-0778
Odell, Ian D. https://orcid.org/0000-0003-3990-6929
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08 AR077689, R03 AR083454)
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 24 September 2025
First Online: 9 October 2025
Competing interests
: IDO and RAF are founders of Plythera, Inc. IDO has received research grants from Ventus Therapeutics and SenTry, Inc, a startup funded by Third Rock Ventures. RAF is a consultant for GSK and Ventus Therapeutics. The remaining authors declare no competing interests.
